1-4 of 4
Hideho Okada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A023: VEGF-neutralization by armored CAR-T cells remodel the tumor microenvironment and enhance antitumor efficacy against solid tumors

Torahito A Gao, Justin D Clubb, Ryan M Shih, Tanya Singh, Gabriella Dibernardo, Amanda Shafer, Amber Bouren, Melanie A Ceja, Sophie Ong, Christine Brown, Hideho Okada, Sanaz Memarzadeh, Han-Chung Wu, Yvonne Y Chen
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): A023.
https://doi.org/10.1158/2326-6074.IO2025-A023
Published: 23 February 2025
View articletitled, Abstract A023: VEGF-neutralization by armored CAR-T cells remodel the tumor microenvironment and enhance antitumor efficacy against solid tumors
Journal Articles

Abstract A029: Overcoming heterogeneous glioblastoma with armored CAR-T cell therapy. Authors: Clubb, J. D., Shih, R., Gao, T., Shafer, A, Vajragiri, S., Talluri, S., Bouren, A., Brown, C. E., Okada, H., Nathanson, D., Chen, Y

Justin D Clubb, Ryan Shih, Torahito Gao, Amanda Shafer, Shreya Vajragiri, Sohan Talluri, Amber Bouren, Christine E Brown, Hideho Okada, David Nathanson, Yvonne Chen
Journal: Cancer Immunology Research
Cancer Immunol Res (2025) 13 (2_Supplement): A029.
https://doi.org/10.1158/2326-6074.IO2025-A029
Published: 23 February 2025
View articletitled, Abstract A029: Overcoming heterogeneous glioblastoma with armored CAR-T cell therapy. Authors: Clubb, J. D., Shih, R., Gao, T., Shafer, A, Vajragiri, S., Talluri, S., Bouren, A., Brown, C. E., Okada, H., Nathanson, D., Chen, Y
Journal Articles

Abstract A117: Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Yafei Hou, Gary Kohanbash, Kaori Okada, Shruti Shrivastav, Matthew Smith-Cohn, Theodore Nicolaides, Sabine Mueller, Angel Montero Carcaboso, Ian F. Pollack, Hideho Okada
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A117.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A117
Published: 03 January 2016
View articletitled, Abstract A117: Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
Journal Articles

STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment

Takayuki Ohkuri, Arundhati Ghosh, Akemi Kosaka, Jianzhong Zhu, Maki Ikeura, Michael David, Simon C. Watkins, Saumendra N. Sarkar, Hideho Okada
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (12): 1199–1208.
https://doi.org/10.1158/2326-6066.CIR-14-0099
Published: 04 December 2014
View articletitled, STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
Open the PDF for STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment in another window
Includes: Supplementary data